VSIG4 anticorps (AA 20-283) (FITC)
Aperçu rapide pour VSIG4 anticorps (AA 20-283) (FITC) (ABIN7175194)
Antigène
Voir toutes VSIG4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 20-283
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human V-set and immunoglobulin domain-containing protein 4 protein (20-283AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VSIG4 (V-Set and Immunoglobulin Domain-Containing Protein 4 (VSIG4))
-
Autre désignation
- VSIG4
-
Sujet
-
Background: Phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. Potent inhibitor of the alternative complement pathway convertases.
Aliases: Complement receptor of the immunoglobulin superfamily antibody, CRIg antibody, Ig superfamily protein antibody, Protein Z39Ig antibody, UNQ317/PRO362 antibody, V set and immunoglobulin domain containing 4 antibody, V-set and immunoglobulin domain-containing protein 4 antibody, VSIG4 antibody, VSIG4_HUMAN antibody, Z39IG antibody
-
UniProt
- Q9Y279
Antigène
-